NEW YORK (360Dx) – With a recent €50,000 ($62,000) Phase I grant from the EU's Horizon 2020 SME Instrumentation program, Swedish microfluidics firm Gradientech plans to explore the potential US market for its QuickMIC antibiotic susceptibility testing system.
Further, said CEO and Cofounder Sara Thorslund, the Phase I award makes the company eligible to receive a Phase II SME Instrumentation award, which totals between €500,000 and €2.5 million.